These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9797457)

  • 1. The in vivo balance between B cell clonal expansion and elimination is regulated by CD95 both on B cells and in their micro-environment.
    Rathmell JC; Goodnow CC
    Immunol Cell Biol; 1998 Oct; 76(5):387-94. PubMed ID: 9797457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells.
    Rathmell JC; Fournier S; Weintraub BC; Allison JP; Goodnow CC
    J Exp Med; 1998 Aug; 188(4):651-9. PubMed ID: 9705947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor.
    Rathmell JC; Townsend SE; Xu JC; Flavell RA; Goodnow CC
    Cell; 1996 Oct; 87(2):319-29. PubMed ID: 8861915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection.
    Cossarizza A; Stent G; Mussini C; Paganelli R; Borghi V; Nuzzo C; Pinti M; Pedrazzi J; Benatti F; Esposito R; Røsok B; Nagata S; Vella S; Franceschi C; De Rienzo B
    AIDS; 2000 Mar; 14(4):345-55. PubMed ID: 10770536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD95 ligand expression as a mechanism of immune escape in breast cancer.
    Müschen M; Moers C; Warskulat U; Even J; Niederacher D; Beckmann MW
    Immunology; 2000 Jan; 99(1):69-77. PubMed ID: 10651943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
    Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
    Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM.
    Giordano C; De Maria R; Stassi G; Todaro M; Richiusa P; Giordano M; Testi R; Galluzzo A
    Diabetologia; 1995 Dec; 38(12):1449-54. PubMed ID: 8786019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors.
    Salmon RA; Foltz IN; Young PR; Schrader JW
    J Immunol; 1997 Dec; 159(11):5309-17. PubMed ID: 9548470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells.
    Rathmell JC; Cooke MP; Ho WY; Grein J; Townsend SE; Davis MM; Goodnow CC
    Nature; 1995 Jul; 376(6536):181-4. PubMed ID: 7603571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis exploits the CD95/CD95 ligand system of gammadelta T cells to cause apoptosis.
    Manfredi AA; Heltai S; Rovere P; Sciorati C; Paolucci C; Galati G; Rugarli C; Vaiani R; Clementi E; Ferrarini M
    Eur J Immunol; 1998 Jun; 28(6):1798-806. PubMed ID: 9645360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR9-mediated signals rescue B-cells from Fas-induced apoptosis via inactivation of caspases.
    Hancz A; Koncz G; Szili D; Sármay G
    Immunol Lett; 2012 Mar; 143(1):77-84. PubMed ID: 22553782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Fas and Fas ligand on spleen T cells of experimental animals after unmodified or leukoreduced allogeneic blood transfusions.
    Hashimoto MN; Kimura EY; Yamamoto M; Bordin JO
    Transfusion; 2004 Feb; 44(2):158-63. PubMed ID: 14962305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity.
    Stranges PB; Watson J; Cooper CJ; Choisy-Rossi CM; Stonebraker AC; Beighton RA; Hartig H; Sundberg JP; Servick S; Kaufmann G; Fink PJ; Chervonsky AV
    Immunity; 2007 May; 26(5):629-41. PubMed ID: 17509906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis.
    Plumas J; Jacob MC; Chaperot L; Molens JP; Sotto JJ; Bensa JC
    Blood; 1998 Apr; 91(8):2875-85. PubMed ID: 9531598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines.
    Peter ME; Dhein J; Ehret A; Hellbardt S; Walczak H; Moldenhauer G; Krammer PH
    Int Immunol; 1995 Nov; 7(11):1873-7. PubMed ID: 8580085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impaired CD95-(Fas,APO-1-)apoptosis regulation is a progression factor in early MALT-type lymphoma genesis].
    Seeberger H; Knörr C; Müller-Hermelink HK; Greiner A
    Med Klin (Munich); 2001 Jan; 96(1):9-14. PubMed ID: 11210492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induced by the antigen receptor and Fas in a variant of the immature B cell line WEHI-231 and in splenic immature B cells.
    Tian MT; Chou CH; DeFranco AL
    Int Immunol; 2001 Apr; 13(4):581-92. PubMed ID: 11282997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD137-induced apoptosis is independent of CD95.
    Michel J; Pauly S; Langstein J; Krammer PH; Schwarz H
    Immunology; 1999 Sep; 98(1):42-6. PubMed ID: 10469232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction.
    Sampalo A; Navas G; Medina F; Segundo C; Cámara C; Brieva JA
    Blood; 2000 Nov; 96(9):3168-74. PubMed ID: 11049999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95.
    Assohou-Luty C; Gerspach J; Siegmund D; Müller N; Huard B; Tiegs G; Pfizenmaier K; Wajant H
    J Mol Med (Berl); 2006 Sep; 84(9):785-97. PubMed ID: 16924474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.